FDA Inspection 1064577 — Roger Bedimo, MD

Roger Bedimo, MD — FEI 3014538968

The FDA completed an inspection of Roger Bedimo, MD on Jul 27, 2018 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)